Omega Therapeutics
Stock Forecast, Prediction & Price Target
Omega Therapeutics Financial Estimates
Omega Therapeutics Revenue Estimates
Omega Therapeutics EBITDA Estimates
Omega Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $144K N/A | $2.07M 1339.58% | $3.09M 49.25% | Avg: $2.49M Low: $954.33K High: $4.30M avg. -19.39% | Avg: $26.93M Low: $13.81M High: $46.02M avg. 980.08% | Avg: $41.77M Low: $21.42M High: $71.36M avg. 55.06% | Avg: $254.47M Low: $130.51M High: $434.77M avg. 509.22% |
Net Income
% change YoY
| $-69.16M N/A | $-102.63M -48.39% | $-97.42M 5.07% | Avg: $-93.77M Low: $-96.67M High: $-44.82M avg. 3.74% | Avg: $-112.43M Low: $-91.27M High: $-46.44M avg. -19.89% | Avg: $-48.06M Low: $-92.34M High: $-17.62M avg. 57.24% | Avg: $-3.24M Low: $-6.22M High: $-1.18M avg. 93.25% |
EBITDA
% change YoY
| $-64.67M N/A | $-102.76M -58.90% | $-93.49M 9.02% | Avg: $-498.79K Low: $-861.44K High: $-190.86K avg. 99.46% | Avg: $-5.38M Low: $-9.20M High: $-2.76M avg. -980.09% | Avg: $-8.35M Low: $-14.27M High: $-4.28M avg. -55.06% | Avg: $-50.89M Low: $-86.95M High: $-26.10M avg. -509.22% |
EPS
% change YoY
| -$1.45 N/A | -$2.14 -47.58% | -$1.8 15.88% | Avg: -$1.2 Low: -$1.79 High: -$0.83 avg. 33.26% | Avg: -$1.15 Low: -$1.69 High: -$0.86 avg. 4.05% | Avg: -$0.89 Low: -$1.71 High: -$0.33 avg. 22.77% | Avg: -$0.06 Low: -$0.12 High: -$0.02 avg. 93.25% |
Operating Expenses
% change YoY
| $66.17M N/A | $104.83M 58.42% | $103.35M -1.41% | Avg: $66.88M Low: $25.59M High: $115.52M avg. -35.28% | Avg: $722.46M Low: $370.54M High: $1.23B avg. 980.08% | Avg: $1.12B Low: $574.57M High: $1.91B avg. 55.06% | Avg: $6.82B Low: $3.50B High: $11.66B avg. 509.22% |
FAQ
What is Omega Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 33.58% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -96.67M, average is -93.77M and high is -44.82M.
What is Omega Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 381.24% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $954.33K, average is $2.49M and high is $4.30M.
What is Omega Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 38.33% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$1.79, average is -$1.2 and high is $-0.83.
What is the best performing analyst?
In the last twelve months analysts have been covering Omega Therapeutics stock. The most successful analyst is Edward Tenthoff.